Hims & Hers Health, Inc.

For the period ended Mar 31, 2026. Filed May 11, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 11, 2026

HIMS$19.13-16.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income

Condensed Consolidated Statements of

Operations and Comprehensive (Loss) Income (Unaudited)

(In Thousands, Except Share and Per Share Data)

	Three Months Ended March 31,
	2026	2025
Revenue	$608,104	$586,010
Cost of revenue	211,317	155,321
Gross profit	396,787	430,689
Operating expenses:
Marketing	222,003	231,235
Operations and support	96,503	63,033
Technology and development	46,936	29,914
General and administrative	109,668	48,610
Total operating expenses	475,110	372,792
(Loss) income from operations	(78,323)	57,897
Other (expense) income:
Change in fair value of equity securities	(9,682)	—
Change in fair value of liabilities	(17,646)	—
Other income, net	4,100	2,598
Total other (expense) income, net	(23,228)	2,598
(Loss) income before income taxes	(101,551)	60,495
Benefit from (provision for) income taxes	9,436	(11,010)
Net (loss) income	(92,115)	49,485
Other comprehensive (loss) income	(6,699)	160
Total comprehensive (loss) income	$(98,814)	$49,645
Net (loss) income per share attributable to common stockholders, Class A and Class V:
Basic	$(0.40)	$0.22
Diluted	$(0.40)	$0.20
Weighted average shares outstanding, Class A and Class V:
Basic	228,357,303	221,989,327
Diluted	228,357,303	246,610,232

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.